Related Experiment Video
Updated: May 8, 2025

Standardized Colon Ascendens Stent Peritonitis in Rats - a Simple, Feasible Animal Model to Induce Septic Acute Kidney Injury
Published on: February 15, 2022
Factors Affecting Continuous Renal Replacement Therapy (CRRT) in Patients With Septic Shock: An Analysis of a
Karan Yagnik1, Gaurav Mohan1, Apurva Ketkar1
1Internal Medicine, Monmouth Medical Center, Long Branch, USA.
Background:
Septic shock is defined as sepsis with hypotension requiring vasopressors to maintain a mean arterial pressure above 65 mmHg and having a serum lactate level of more than 2 mmol/L despite adequate volume resuscitation as per the Sepsis-3 criteria. Continuous renal replacement therapy (CRRT) is commonly utilized in septic shock patients for the treatment of acute kidney injury as well as for modulating immune response and maintaining hemodynamic stability.
Methods:
We looked at the National Inpatient Sample database in 2019. We identified adult patients with septic shock as the primary diagnosis using the International Classification of Diseases, 10th revision, clinical modification codes R65.21 and R78.81, and subbranches of Aa41, A40, and R60. STATA 18 (StataCorp, College Station, TX) was used to perform logistic multivariate regression analyses.
Results:
A total of 15,794 adults who were admitted for septic shock as the primary diagnosis underwent CRRT. The mean age of the patients was 61.7 years. The overall mortality rate was 57% (N = 9,002). An increase in age by one year was associated with a 1% increase in mortality (p = 0.001). The presence of hypertension increased mortality by 29% (N = 6,391) (p = 0.028). Interestingly, preexisting diabetes mellitus improved mortality by 37% (N = 3331) (p = 0.001).The outcome of CRRT was better in patients with chronic kidney disease, with a 26% improvement in mortality (N = 2341) (p = 0.001). A significant improvement in outcome (29% decrease in mortality, p=0.013) and 31% reduction in hospital length of stay (p = 0.008) was noted with CRRT initiated on day 2 of hospitalization.
Conclusion:
This study highlights that the approximate time of initiation of CRRT for optimal benefit of the treatment is between 24 and 48 hours of hospitalization. This study emphasizes the prognostic factors of a standard therapy, which can serve as a basis for clinical decision-making.
Related Concept Videos
Renal Failure: Dose Adjustments
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Factors Affecting Renal Clearance: Renal Impairment
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
Dialysis
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
Factors Affecting Renal Clearance: Drug's Physicochemical Properties and Plasma Levels
One important factor is the drug's molecular size. The kidneys readily excrete smaller molecules below 300 Daltons (Da). On the other hand, molecules weighing between 300 and 500 Da are excreted through both urine and bile. Larger molecules above 500 Da tend to be excreted...
Acute Respiratory Failure-V
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Factors Affecting Renal Clearance: Drug Distribution and Drug Interactions
One important factor is the relationship between renal clearance and the apparent volume of distribution. Renal clearance tends to be inversely proportional to the apparent volume of distribution. Drugs with an extensive distribution volume or those...

